ENCell Co Ltd
KOSDAQ:456070
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10 040
20 700
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| KR |
E
|
ENCell Co Ltd
KOSDAQ:456070
|
163.4B KRW |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.2T USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
238.3B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
169.4B USD |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
38B CHF |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
40.9B USD |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
281.9B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
39.2B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
46.3T KRW |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
29B USD |
Loading...
|
|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
20.1B EUR |
Loading...
|
Market Distribution
| Min | -163 055.6% |
| 30th Percentile | -2.2% |
| Median | 2.7% |
| 70th Percentile | 6.8% |
| Max | 22 874.8% |
Other Profitability Ratios
ENCell Co Ltd
Glance View
ENCell Co Ltd is a KR-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-08-23. ENCell Co Ltd is a Korea-based company principally engaged in the development and research of new drugs. The firm is principally engaged in the development and research of cell and gene-based biopharmaceuticals. The firm is also engaged in the provision of biopharmaceutical quality testing services. In addition, the Company is engaged in the biopharmaceutical consignment production business.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for ENCell Co Ltd is -312.6%, which is below its 3-year median of -260.2%.
Over the last 1 years, ENCell Co Ltd’s Operating Margin has decreased from -136.7% to -312.6%. During this period, it reached a low of -324.1% on Jun 30, 2025 and a high of -136.7% on Aug 30, 2024.